Hedge Funds

Healthcare Hedge Fund Rhenman Eyes “intense” Covid-19 Vaccine Activity

by hedgeweek.com posted 11months ago 143 views
Healthcare hedge fund Rhenman eyes “intense” Covid-19 vaccine activity Submitted By Hugh Leask | 07/08/2020 - 1:44pm Rhenman & Partners Asset Management, a Stockholm-based hedge fund firm which invests in global healthcare stocks, is optimistic about a post-US election market bounce, and points to “intense activity” among vaccine developers working on a treatment for Covid-19. The firm’s Rhenman Healthcare Equity Long/Short Fund – which trades a range of small, medium and large pharmaceuticals, biotechnology, medical technology and service company stocks – was down in July.

In this article